Fig. 3From: Clinical characteristics of patients from Quebec, Canada, with Morquio A syndrome: a longitudinal observational studyIndividual patient 6-min walk test distances over time following treatment with elosulfase alfa. Note for patient 28, distance improved to 153Â m, but this was with a walker and has not been included on the figure. 1171A>G: founder pathogenic variantBack to article page